Vincent Blancheteau

Highly motivated PhD scientist with more than 10 years of international experience in the biotech industry.

2 years as cell therapies scientist/flow cytometry specialist.

7 years of academic research and over 9 years in the bio-industry.

Strong background in immunobiology, cell biology and molecular biology.

Productive scientist with good communications & team skills, solution-orientated critical analysis and scientific curiosity.

Energetic, enthusiast, self-motivated, flexible and able to perform individually and as part of a team.

EMPLOYMENT HISTORY

May 2022 – Present Scientist / Flow Cytometry Specialist, Antion Biosciences SA (Geneva)

Development of CAR-based engineered cell therapies (T, NK, Treg).
Management of flow cytometry capabilities across the company.
Scientific expertise in the design and execution of in vitro experiments aimed at advancing company's CAR-based engineered cell therapies.
Co-management of preclinical mouse models studies (CROs).

Jan 2018 – Apr 2022 Associate Study Manager/FACS Lead, Oncodesign (Dijon, France)

FACS Lead: Development, optimization, implementation, support of flow cytometry-based services across the company.
Development, optimization, implementation of in vitro/ex vivo assays for customers’ studies, with mouse models of cancer/immuno-oncology (humanised, CDX, PDX); Co-management of customers’ studies.
Training/support of staff.

Aug 2016 – Dec 2017 Cell Biology/Immunology Scientist, Essen Bioscience (UK)

Development of advanced live-cell imaging assays for IncuCyte Live-Cell imaging systems; Implementation of flow cytometry capabilities.

May 2016 – July 2016 Bioassay specialist, Orphidia Ltd (UK)

Development, optimization of microELISA for PoC diagnostics microfluidic device.

Aug 2014 – Apr 2016 Discovery/Preclinical Scientist, Anokion SA (Lausanne, Switzerland)

Design, planning, implementation and reporting of discovery/preclinical in vivo/ex vivo studies for pipeline programs

Jan 2013 – July 2014 Research Scientist Biomicrofluidics, Sanofi-Aventis/ESPCI (Paris)

Development of droplet-based microfluidics assay for antibiotics screening

Sept 2009 – Dec 2012 Immunotherapeutics Senior Scientist, Apitope Technology Ltd (UK)

Discovery projects of peptide therapeutics for treatment of autoimmune diseases

(multiple sclerosis, haemophilia, Grave’s disease); support scientist for company’s clinical assays.

May 2007 – Aug 2009 Drug discovery postdoctoral researcher, LUMC (Leiden)

Development of small molecule inhibitors for a tyrosine kinase (Oncology).

March 2006 – May 2007 Postdoctoral research fellow, Princess Margaret Hospital (Toronto)

Differentiation/expansion of human mesenchymal stem cells.

Dec 2002 – Dec 2005 Research associate, Imperial College London

Research: Proteomic analysis of phagosome maturation in Dictyostelium discoideum.

Oct 2001 – Oct 2002 Postdoctoral research fellow, Institute of Biochemistry (Lausanne)

Cloning and characterisation of a novel adaptor protein involved in TLR signalling

2002 PhD in Cell Biology/Immunobiology (“biology of blood cells”), University Paris VII, France

1997 Maitrise (M.Sc.) in Biochemistry, University Paris VI, France